Skip to main content
Watch Insiders
HOWL filings

Corporate insider profile

Peter Kolchinsky Filing Activity

Latest reported as Corporate insider of Werewolf Therapeutics, Inc. (HOWL).

Purchase filings
9
Reported companies
5
Net open-market value
$540,858,775
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

HOWLLatest reported

Werewolf Therapeutics, Inc.

Corporate insider

COAGPrior filing

Hemab Therapeutics Holdings, Inc.

Corporate insider

ARTVPrior filing

Artiva Biotherapeutics, Inc.

Corporate insider

PBLSPrior filing

Parabilis Medicines, Inc.

Corporate insider

VORPrior filing

Vor Biopharma Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Werewolf Therapeutics, Inc. (HOWL)Corporate insiderSale416,911$0.35$145,919
Jun 16, 2026Hemab Therapeutics Holdings, Inc. (COAG)Corporate insiderOpen Market Purchase67,669$24.97$1,689,817
Jun 16, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase531,326$8.66$4,599,902
Subscribe to see more data